CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,032,885
- in 7 filings, $3.7M under 10b5-1 plans
Net −$4,032,885. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,161 | $84.43 | $98K | 205,695 |
| 2025-01-02 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 10,638 | ||
| 2024-12-31 | Wassil Jim CHIEF OPERATING OFFICER | Gift | −74,000 | 131,695 | ||
| 2024-12-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 117,491 |
| 2024-12-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −1,190 | $87.26 | $104K | 116,301 |
| 2024-12-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −3,373 | $88.70 | $299K | 112,928 |
| 2024-12-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −3,157 | $89.31 | $282K | 109,771 |
| 2024-12-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −280 | $90.24 | $25K | 109,491 |
| 2024-12-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 262,827 | ||
| 2024-12-16 | Cowan Elvia SVP, FINANCE | Option exercise | +7,716 | $25.92 | $200K | 19,294 |
| 2024-12-16 | Cowan Elvia SVP, FINANCE | Option exercise · Stock Option (right to buy) | −7,716 | 106,284 | ||
| 2024-12-09 | Paya Carlos V Director | Gift · Stock Option (right to buy) | −7,250 | 0 | ||
| 2024-12-09 | Paya Carlos V Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2024-12-09 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −961 | $92.06 | $88K | 136,437 |
| 2024-12-09 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −222 | $93.10 | $21K | 136,215 |
| 2024-12-09 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,029 | $92.03 | $95K | 136,369 |
| 2024-12-09 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −154 | $93.60 | $14K | 136,215 |
| 2024-12-09 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Shares withheld for taxes 10b5-1 | −475 | $92.06 | $44K | 28,222 |
| 2024-12-06 | Paya Carlos V Director | Gift | −2,500 | 1,550 | ||
| 2024-12-06 | Paya Carlos V Director | Grant or award | +2,500 | 5,625 |
Page 15 of 16 · 319 trades